Author:
Carroll John D.,Edwards Fred H.,Marinac-Dabic Danica,Brindis Ralph G.,Grover Frederick L.,Peterson Eric D.,Tuzcu E. Murat,Shahian David M.,Rumsfeld John S.,Shewan Cynthia M.,Hewitt Kathleen,Holmes David R.,Mack Michael J.
Funder
Eli Lilly, Janssen Pharmaceuticals, Pfizer, and Boehringer Ingleheim
Subject
Cardiology and Cardiovascular Medicine
Reference35 articles.
1. Achieving meaningful device surveillance: from reaction to proaction;Rumsfeld;JAMA,2010
2. Here we go again—another failure of postmarketing device surveillance;Hauser;N Engl J Med,2012
3. Brief Summary of the Circulatory System Devices Panel Meeting, June 13, 2012. Available at: http://www.fda.gov/advisorycommittees/committeesmeetingmaterials/medicaldevices/medicaldevicesadvisorycommittee/circulatorysystemdevicespanel/ucm300073.htm. Accessed December 31, 2012.
4. FDA Expands Approved Use of Sapien Artificial Heart Valve. Available at: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm323478.htm. Accessed January 10, 2013.
5. Rational dispersion for the introduction of transcatheter valve therapy;Mack;JAMA,2011
Cited by
196 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献